DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $618 | -36.3% | 2,489 | -38.4% | 0.05% | -3.8% |
| Q2 2023 | $970 | +50.9% | 4,040 | +66.7% | 0.05% | +89.3% |
| Q1 2023 | $643 | 0.0% | 2,424 | 0.0% | 0.03% | 0.0% |
| Q4 2022 | $643 | -99.9% | 2,424 | -30.6% | 0.03% | -30.0% |
| Q3 2022 | $902,000 | +4.9% | 3,494 | +3.0% | 0.04% | +25.0% |
| Q2 2022 | $860,000 | -46.3% | 3,391 | -37.9% | 0.03% | -40.7% |
| Q1 2022 | $1,601,000 | -26.0% | 5,458 | -17.0% | 0.05% | -10.0% |
| Q4 2021 | $2,163,000 | +4.7% | 6,574 | -3.1% | 0.06% | -9.1% |
| Q3 2021 | $2,065,000 | +5.5% | 6,783 | -7.0% | 0.07% | +1.5% |
| Q2 2021 | $1,958,000 | +6.9% | 7,295 | -10.4% | 0.06% | -5.8% |
| Q1 2021 | $1,832,000 | -10.0% | 8,141 | -11.1% | 0.07% | -17.9% |
| Q4 2020 | $2,035,000 | +3.0% | 9,162 | -0.1% | 0.08% | -8.7% |
| Q3 2020 | $1,975,000 | +0.6% | 9,172 | -17.4% | 0.09% | -10.7% |
| Q2 2020 | $1,963,000 | +36.0% | 11,100 | +6.4% | 0.10% | +9.6% |
| Q1 2020 | $1,443,000 | -10.8% | 10,429 | -1.0% | 0.09% | +5.6% |
| Q4 2019 | $1,617,000 | +14.0% | 10,536 | +7.2% | 0.09% | -9.2% |
| Q3 2019 | $1,419,000 | -50.2% | 9,827 | -50.7% | 0.10% | -12.5% |
| Q2 2019 | $2,849,000 | +39.4% | 19,932 | +28.8% | 0.11% | +34.9% |
| Q1 2019 | $2,044,000 | +8.3% | 15,479 | -15.4% | 0.08% | -46.5% |
| Q4 2018 | $1,887,000 | -23.1% | 18,296 | -19.0% | 0.16% | +70.3% |
| Q3 2018 | $2,454,000 | +30.7% | 22,585 | +18.6% | 0.09% | +33.8% |
| Q2 2018 | $1,878,000 | -47.1% | 19,035 | -47.5% | 0.07% | -35.8% |
| Q1 2018 | $3,548,000 | +5.8% | 36,235 | +0.3% | 0.11% | +16.5% |
| Q4 2017 | $3,354,000 | +6.3% | 36,139 | -1.7% | 0.09% | +4.6% |
| Q3 2017 | $3,154,000 | +7.9% | 36,768 | +6.1% | 0.09% | 0.0% |
| Q2 2017 | $2,923,000 | +0.8% | 34,641 | +2.1% | 0.09% | -2.2% |
| Q1 2017 | $2,901,000 | -1.5% | 33,913 | -10.4% | 0.09% | +4.7% |
| Q4 2016 | $2,945,000 | -3.6% | 37,834 | -3.0% | 0.08% | -33.1% |
| Q3 2016 | $3,056,000 | -6.2% | 38,987 | +20.9% | 0.13% | -13.6% |
| Q2 2016 | $3,257,000 | +10.3% | 32,250 | +3.5% | 0.15% | +8.9% |
| Q1 2016 | $2,954,000 | -5.9% | 31,145 | -7.8% | 0.14% | -4.9% |
| Q4 2015 | $3,138,000 | -99.9% | 33,784 | -2.3% | 0.14% | -43.9% |
| Q3 2015 | $2,947,926,000 | +83790.9% | 34,596 | -16.8% | 0.25% | +45.4% |
| Q2 2015 | $3,514,000 | +12.8% | 41,588 | +13.3% | 0.17% | +152.2% |
| Q1 2015 | $3,115,000 | -19.4% | 36,700 | -18.6% | 0.07% | -70.6% |
| Q4 2014 | $3,865,000 | +2.3% | 45,089 | -9.3% | 0.24% | -4.1% |
| Q3 2014 | $3,777,000 | +4.9% | 49,717 | +8.7% | 0.24% | +3.8% |
| Q2 2014 | $3,602,000 | +34.5% | 45,753 | +28.1% | 0.24% | +5.8% |
| Q1 2014 | $2,678,000 | +54.6% | 35,713 | +59.1% | 0.22% | +28.9% |
| Q4 2013 | $1,732,000 | +45.9% | 22,442 | +31.0% | 0.17% | +23.6% |
| Q3 2013 | $1,187,000 | +0.6% | 17,125 | -8.2% | 0.14% | -10.3% |
| Q2 2013 | $1,180,000 | – | 18,645 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |